Bucladesine: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
No edit summary |
||
| Line 27: | Line 27: | ||
==Overview== | ==Overview== | ||
'''Bucladesine''' is a [[phosphodiesterase inhibitor]]. | '''Bucladesine''' is a cyclic nucleotide derivative which mimics the action of endogenous [[Cyclic adenosine monophosphate|cAMP]] and is a [[phosphodiesterase inhibitor]]. | ||
Bucladesine is a cell permeable cAMP analog. The compound is used in a wide variety of research applications because it mimics cAMP and can induce normal physiological responses when added to cells in experimental conditions. cAMP is only able to elicit minimal responses in these situations. | |||
The [[neurite]] outgrowth instigated by bucladesine in cell cultures has been shown to be enhanced by nardosinone. | |||
{{Phosphodiesterase inhibitors}} | {{Phosphodiesterase inhibitors}} | ||
| Line 33: | Line 37: | ||
[[Category:Phosphodiesterase inhibitors]] | [[Category:Phosphodiesterase inhibitors]] | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 19:21, 24 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C18H23N5NaO8P |
| Molar mass | 491.368 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bucladesine is a cyclic nucleotide derivative which mimics the action of endogenous cAMP and is a phosphodiesterase inhibitor.
Bucladesine is a cell permeable cAMP analog. The compound is used in a wide variety of research applications because it mimics cAMP and can induce normal physiological responses when added to cells in experimental conditions. cAMP is only able to elicit minimal responses in these situations.
The neurite outgrowth instigated by bucladesine in cell cultures has been shown to be enhanced by nardosinone.
Template:Phosphodiesterase inhibitors Template:Cardiac stimulants excluding cardiac glycosides
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Phosphodiesterase inhibitors
- Cardiovascular Drugs
- Drugs